Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pelvic Neoplasms × Vorinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 12 Carcinoma, Non-Small-Cell Lung 12 Lymphoma, Large B-Cell, Diffuse 11 Hodgkin Disease 11 Lymphoma, Non-Hodgkin 10 Lymphoma 10 Lymphoma, Follicular 8 Lymphoma, Mantle-Cell 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Burkitt Lymphoma 7 Breast Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Recurrence 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Blast Crisis 6 Sezary Syndrome 5 Neuroblastoma 5 Neoplasms 5 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Mycosis Fungoides 5 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Extranodal NK-T-Cell 5 Lymphoma, B-Cell, Marginal Zone 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4

Interventions

Vorinostat 1 Sunitinib 1 Lidocaine 1 Ketamine 1 FS 069 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455351 2023-05-08

PRAVO

Oslo University Hospital

Phase 1 Completed

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡